Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
Titel:
Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial
Auteur:
Chan, Arlene Moy, Beverly Mansi, Janine Ejlertsen, Bent Holmes, Frankie Ann Chia, Stephen Iwata, Hiroji Gnant, Michael Loibl, Sibylle Barrios, Carlos H. Somali, Isil Smichkoska, Snezhana Martinez, Noelia Alonso, Mirta Garcia Link, John S. Mayer, Ingrid A. Cold, Søren Murillo, Serafin Morales Senecal, Francis Inoue, Kenichi Ruiz-Borrego, Manuel Hui, Rina Denduluri, Neelima Patt, Debra Rugo, Hope S. Johnston, Stephen R.D. Bryce, Richard Zhang, Bo Xu, Feng Wong, Alvin Martin, Miguel